807 related articles for article (PubMed ID: 30182846)
1. Exosome-like Nanovectors for Drug Delivery in Cancer.
Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
[TBL] [Abstract][Full Text] [Related]
2. Engineering exosomes as refined biological nanoplatforms for drug delivery.
Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
[TBL] [Abstract][Full Text] [Related]
3. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
6. Exosomes: Isolation, Analysis, and Applications in Cancer Detection and Therapy.
Bu H; He D; He X; Wang K
Chembiochem; 2019 Feb; 20(4):451-461. PubMed ID: 30371016
[TBL] [Abstract][Full Text] [Related]
7. Exosomes: cell-created drug delivery systems.
Familtseva A; Jeremic N; Tyagi SC
Mol Cell Biochem; 2019 Sep; 459(1-2):1-6. PubMed ID: 31073888
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
[TBL] [Abstract][Full Text] [Related]
9. Milk Exosomes: Perspective Agents for Anticancer Drug Delivery.
Sedykh S; Kuleshova A; Nevinsky G
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932782
[TBL] [Abstract][Full Text] [Related]
10. Exosome mimetics: a novel class of drug delivery systems.
Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
[TBL] [Abstract][Full Text] [Related]
11. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
12. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
13. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
[TBL] [Abstract][Full Text] [Related]
14. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
[TBL] [Abstract][Full Text] [Related]
15. Exosome vesicle as a nano-therapeutic carrier for breast cancer.
Mughees M; Kumar K; Wajid S
J Drug Target; 2021 Feb; 29(2):121-130. PubMed ID: 32787592
[TBL] [Abstract][Full Text] [Related]
16. Exosomes: the ideal nanovectors for biodelivery.
Fais S; Logozzi M; Lugini L; Federici C; Azzarito T; Zarovni N; Chiesi A
Biol Chem; 2013 Jan; 394(1):1-15. PubMed ID: 23241589
[TBL] [Abstract][Full Text] [Related]
17. Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles.
Busatto S; Pham A; Suh A; Shapiro S; Wolfram J
Biomed Microdevices; 2019 Apr; 21(2):46. PubMed ID: 30989386
[TBL] [Abstract][Full Text] [Related]
18. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
19. Post isolation modification of exosomes for nanomedicine applications.
Hood JL
Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
